X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket

被引:4
作者
Lountos, George T. [1 ,2 ]
Jobson, Andrew G. [3 ]
Tropea, Joseph E. [1 ]
Self, Christopher R. [4 ]
Zhang, Guangtao [4 ]
Pommier, Yves [3 ]
Shoemaker, Robert H. [5 ]
Waugh, David S. [1 ]
机构
[1] NCI, Macromol Crystallog Lab, Ctr Canc Res, Frederick, MD 21702 USA
[2] SAIC Frederick, Basic Sci Program, Frederick, MD 21702 USA
[3] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[4] Provid Pharmaceut, Monmouth Jct, NJ 08852 USA
[5] NCI, Screening Technol Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21702 USA
基金
美国国家卫生研究院;
关键词
Rational drug design; Structure-based drug design; Kinase inhibitors; CHK2; PROTEIN-KINASE; SELECTIVE INHIBITOR; DNA-DAMAGE; PHOSPHORYLATION; BRCA1; AUTOPHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; RADIATION; APOPTOSIS;
D O I
10.1016/j.febslet.2011.08.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The serine/threonine checkpoint kinase 2 (Chk2) is an attractive molecular target for the development of small molecule inhibitors to treat cancer. Here, we report the rational design of Chk2 inhibitors that target the gatekeeper-dependent hydrophobic pocket located behind the adenine-binding region of the ATP-binding site. These compounds exhibit IC(50) values in the low nanomolar range and are highly selective for Chk2 over Chk1. X-ray crystallography was used to determine the structures of the inhibitors in complex with the catalytic kinase domain of Chk2 to verify their modes of binding. Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:3245 / 3249
页数:5
相关论文
共 33 条
  • [1] Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
    Ahn, JY
    Li, XH
    Davis, HL
    Canman, CE
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (22) : 19389 - 19395
  • [2] Ahn JY, 2000, CANCER RES, V60, P5934
  • [3] CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?
    Antoni, Laurent
    Sodha, Nayanta
    Collins, Ian
    Garrett, Michelle D.
    [J]. NATURE REVIEWS CANCER, 2007, 7 (12) : 925 - 936
  • [4] Checkpoint kinase inhibitors: SAR and radioprotective properties of a series of 2-arylbenzimidazoles
    Arienti, KL
    Brunmark, A
    Axe, FU
    McClure, K
    Lee, A
    Blevitt, J
    Neff, DK
    Huang, LM
    Crawford, S
    Pandit, CR
    Karlsson, L
    Breitenbucher, JG
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1873 - 1885
  • [5] Biochemical and cellular characterization of VRX0466617, a novel and selective inhibitor for the checkpoint kinase Chk2
    Carlessi, Luigi
    Buscemi, Giacomo
    Larson, Gary
    Hong, Zhi
    Wu, Jim Zhen
    Delia, Domenico
    [J]. MOLECULAR CANCER THERAPEUTICS, 2007, 6 (03) : 935 - 944
  • [6] Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy
    Castedo, M
    Perfettini, JL
    Roumier, T
    Valent, A
    Raslova, H
    Yakushijin, K
    Horne, D
    Feunteun, J
    Lenoir, G
    Medema, R
    Vainchenker, W
    Kroemer, G
    [J]. ONCOGENE, 2004, 23 (25) : 4362 - 4370
  • [7] BRCA1 is regulated by Chk2 in response to spindle damage
    Chabalier-Taste, Corinne
    Racca, Carine
    Dozier, Christine
    Larminat, Florence
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2008, 1783 (12): : 2223 - 2233
  • [8] MolProbity: all-atom contacts and structure validation for proteins and nucleic acids
    Davis, Ian W.
    Leaver-Fay, Andrew
    Chen, Vincent B.
    Block, Jeremy N.
    Kapral, Gary J.
    Wang, Xueyi
    Murray, Laura W.
    Arendall, W. Bryan, III
    Snoeyink, Jack
    Richardson, Jane S.
    Richardson, David C.
    [J]. NUCLEIC ACIDS RESEARCH, 2007, 35 : W375 - W383
  • [9] Inactivation of Chk2 and Mus81 Leads to Impaired Lymphocytes Development, Reduced Genomic Instability, and Suppression of Cancer
    El Ghamrasni, Samah
    Pamidi, Ashwin
    Halaby, Marie Jo
    Bohgaki, Miyuki
    Cardoso, Renato
    Li, Li
    Venkatesan, Shriram
    Sethu, Swaminathan
    Hirao, Atsushi
    Mak, Tak W.
    Hande, Manoor Prakash
    Hakem, Anne
    Hakem, Razqallah
    [J]. PLOS GENETICS, 2011, 7 (05)
  • [10] Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification
    Foloppe, N
    Fisher, LM
    Francis, G
    Howes, R
    Kierstan, P
    Potter, A
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (06) : 1792 - 1804